Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Sean Laaman Analyst Performance

Analyst at Morgan Stanley

Sean Laaman is a stock analyst at Morgan Stanley in the healthcare sector, covering 22 publicly traded companies. Over the past year, Sean Laaman has issued 53 stock ratings, including buy, hold, and sell recommendations. While full access to Sean Laaman's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean Laaman's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
67 Last 6 Years
Buy Recommendations
71.19% 42 Buy Ratings
Companies Covered
22 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy71.2%42 ratings
Hold23.7%14 ratings
Sell5.1%3 ratings

Out of 59 total stock ratings issued by Sean Laaman at Morgan Stanley, the majority (71.2%) have been Buy recommendations, followed by 23.7% Hold and 5.1% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
95.5% of companies on NASDAQ
21 companies
NYSE
4.5% of companies on NYSE
1 company

Sean Laaman, an analyst at Morgan Stanley, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
22 companies
100.0%

Sean Laaman of Morgan Stanley specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
18 companies
81.8%
PHARMACEUTICALS
2 companies
9.1%
HEALTHCARE TECHNOLOGY
1 company
4.5%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
4.5%

Sean Laaman's Ratings History at Morgan Stanley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
argenex SE stock logo
ARGX
argenex
10/23/2026Boost Price Target$877.31$1,190.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
10/21/2026Lower Price Target$68.27$87.00Overweight
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
10/21/2026Lower Price Target$2.73$13.00Overweight
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
10/20/2026Reiterated Rating$8.54Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
10/20/2026Boost Price Target$78.62$92.00Overweight
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
10/20/2026Reiterated Rating$17.99Overweight
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
10/20/2026Set Price Target$38.50$42.00
Bicara Therapeutics Inc. stock logo
BCAX
Bicara Therapeutics
10/20/2026Set Price Target$17.47$41.00
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
10/20/2026Set Price Target$8.22$20.00
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
10/16/2026Set Price Target$3.82$5.90
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
10/16/2026Reiterated Rating$368.09$425.00Overweight
Alector, Inc. stock logo
ALEC
Alector
10/6/2026Boost Price Target$1.99$3.00Underweight
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
10/2/2026Initiated Coverage$46.21$70.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
9/25/2026Lower Price Target$196.76$247.00Equal Weight
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
9/10/2026Initiated Coverage$207.68$255.00Overweight
argenex SE stock logo
ARGX
argenex
8/31/2026Boost Price Target$1,017.28$1,250.00Overweight
argenex SE stock logo
ARGX
argenex
8/18/2026Boost Price Target$987.87$1,230.00Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
8/17/2026Reiterated Rating$78.66$90.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/11/2026Boost Price Target$217.91$251.00Equal Weight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
8/11/2026Lower Price Target$84.04$97.00Overweight
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
7/28/2026Reiterated Rating$9.90$21.00Equal Weight
Exelixis, Inc. stock logo
EXEL
Exelixis
7/23/2026Boost Price Target$55.68$53.00Equal Weight
Erasca, Inc. stock logo
ERAS
Erasca
7/20/2026Boost Price Target$19.17$21.00Equal Weight
Exelixis, Inc. stock logo
EXEL
Exelixis
6/22/2026Reiterated Rating$51.35Positive
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
6/15/2026Boost Price Target$70.09$85.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
6/11/2026Upgrade$246.34Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
5/28/2026Boost Price Target$65.98$98.00Overweight
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
5/14/2026Boost Price Target$15.88$22.00Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
5/14/2026Boost Price Target$69.30$80.00Overweight
Certara, Inc. stock logo
CERT
Certara
5/12/2026Lower Price Target$5.13$10.00Equal Weight
Exelixis, Inc. stock logo
EXEL
Exelixis
5/6/2026Boost Price Target$48.45$50.00Equal Weight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/5/2026Boost Price Target$227.99$242.00Equal Weight
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
3/24/2026Initiated Coverage$12.52$20.00Overweight
EIKN
Eikon Therapeutics
3/2/2026Initiated Coverage$13.78$32.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
2/25/2026Boost Price Target$66.71$98.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/24/2026Set Price Target$170.97$207.00
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
2/17/2026Set Price Target$60.55$75.00
Exelixis, Inc. stock logo
EXEL
Exelixis
2/2/2026Boost Price Target$41.23$49.00Equal Weight
Erasca, Inc. stock logo
ERAS
Erasca
1/26/2026Set Price Target$9.96$10.00
CG Oncology, Inc. stock logo
CGON
CG Oncology
1/9/2026Set Price Target$54.23$93.00
Why Gerardo Del Real says wait before buying uranium stocks (Ad)

Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.tc pixel

Watch Gerardo Del Real's new uranium market breakdown now
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
1/8/2026Reiterated Rating$333.87$405.00Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
1/8/2026Reiterated Rating$80.94$120.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/8/2026Downgrade$170.69Reduce
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/8/2026Reiterated Rating$170.69$204.00Equal Weight
Exelixis, Inc. stock logo
EXEL
Exelixis
1/8/2026Reiterated Rating$46.19$48.00Equal Weight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
1/6/2026Initiated Coverage$73.42$96.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
12/31/2025Reiterated Rating$183.22Overweight
Certara, Inc. stock logo
CERT
Certara
12/18/2025Lower Price Target$9.10$12.00Equal Weight
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
11/21/2025Initiated Coverage$13.29$34.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Boost Price Target$40.36$45.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Boost Price Target$133.96$196.00Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
10/30/2025Boost Price Target$85.75$115.00Overweight
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
10/27/2025Boost Price Target$31.98$34.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
10/21/2025Lower Price Target$35.32$44.00Overweight
ResMed Inc. stock logo
RMD
ResMed
10/21/2025Boost Price Target$271.44$304.00Overweight
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
10/20/2025Boost Price Target$318.05$383.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
10/20/2025Boost Price Target$127.94$194.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
9/17/2025Boost Price Target$40.54$50.00Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
8/18/2025Boost Price Target$60.07$90.00Overweight
Exelixis, Inc. stock logo
EXEL
Exelixis
7/29/2025Lower Price Target$37.20$46.00Overweight
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
7/3/2025Initiated Coverage$53.17$85.00Overweight
Certara, Inc. stock logo
CERT
Certara
7/3/2025Initiated Coverage$11.49$16.00Equal Weight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
7/3/2025Initiated Coverage$103.91$190.00Overweight
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
6/27/2025Boost Price Target$244.34$330.00Overweight
Alector, Inc. stock logo
ALEC
Alector
3/7/2025Reiterated Rating$1.48$1.50Underweight